Abstract

O
I value the support and hard work by all of the authors and Moshe Phillip's and Tadei Battelino's leadership in bringing out the Yearbook annually.
Beginning in 2014, our relationship with ATTD is expanding—I am pleased to say that DTT has been named the Official Journal of ATTD. The partnership between ATTD and DTT is obvious because they represent the leading conference and journal, respectively, in the field of new technologies and treatments for diabetes.
We will also be publishing the abstracts from the upcoming ATTD 2014 meeting—the 7th International Conference on ATTD to be held in Vienna, Austria, on February 5–8, 2014.
I want to wish you all a happy and prosperous New Year. Please feel free to send me your comments so that we can improve and implement changes in the ATTD Yearbook every year.
